Business
Investor buzz around cannabis stocks with new treatments – Sydney Morning Herald
Cannabis startups get down to business as treatments normalised and some small stocks are winning big name backers.
Last week ASX-listed Zelira Therapeutics, formerly Zelda Therapeutics, scored a new substantial shareholder when billionaire investor Alex Waislitz’s Thorney Investment Group upped its stake from 2 per cent to 5.2 per cent.
Earlier this month Zelira confirmed its cannabinoid insomnia medicine Zenivol had been made available in Australia under the nation’s special access scheme for cannabis products.
Thorney bumped its stake after a private placement of 37 million shares at 5.4c each.
“The str…
-
Noosa News24 hours agoCleveland line train services halted after truck crash at Pine Street bridge in Wynnum
-
General22 hours agoBrisbane homelessness services report 48 per cent increase in number of children being supported
-
Noosa News23 hours agoCoroner to rule if police were justified in deadly 2022 standoff with knife-wielding man at McDonald’s Marsden
-
Noosa News6 hours agoWoman and two boys killed in Gladstone house fire identified